Legal analysis: can be reimbursed. Basic medical insurance to pay part of the cost of diagnosis and treatment program scope: (a) diagnostic and treatment equipment and medical materials category 1, the application of X-ray computed tomography device (CT), stereotactic radiography device (γ-knife, χ-knife), cardiac and angiography X-ray machine (including digital subtraction equipment), Magnetic **** vibration imaging device (MEI), single photon emission computer scanning device (SPECT), color Doppler, medical linear gas pedal and other large medical equipment for examination, treatment projects; 2, extracorporeal shock wave lithotripsy and hyperbaric oxygen therapy; 3, pacemaker, artificial joints, artificial crystals, vascular stents in vivo replacement of artificial organs, in vivo replacement of materials; 4, the provincial price department provides for separate charges. Provincial price department regulations can be charged separately for disposable medical materials. (B) treatment project category 1, hemodialysis, peritoneal dialysis; 2, kidney, heart valves, cornea, skin, blood vessels, bone, bone marrow transplantation; 3, cardiac laser perforation, anti-tumor cellular immunotherapy and fast neutron therapy projects. (C) Treatment items category 1, organ source or tissue source for various types of organ transplantation or tissue transplantation; 2, organ or tissue transplantation other than kidney, heart valve, cornea, skin, blood vessel, bone and bone marrow transplantation; 3, myopic eye orthopedics; 4, qigong therapy, music therapy, health care nutritional therapy, magnetic therapy and other complementary therapeutic items. (D) other 1, a variety of infertility (pregnancy), sexual dysfunction diagnosis and treatment programs; 2, a variety of scientific research, clinical verification of diagnosis and treatment programs;
Legal basis: "Chinese People's Republic of China *** and the State of basic medical care and health promotion law" Article 59 The State implements the basic medicines system, the selection of an appropriate number of varieties of basic medicines, to meet the basic needs of medicines for the prevention and treatment of disease. The State publishes a list of essential medicines, and dynamically adjusts the list of essential medicines in accordance with the practice of clinical application of medicines, changes in drug standards, and new listings of medicines. Basic medicines are prioritized for inclusion in the basic medical insurance drug list in accordance with regulations. The state improves the supply capacity of essential medicines, strengthens the quality supervision of essential medicines, and ensures that essential medicines are equitably accessible and rationally utilized.